18 A multi-center, phase II clinical trial of genexol(paclitaxel) and cisplatin in patients with non-small cell lung cancer

Lung Cancer ◽

10.1016/s0169-5002(03)92709-7 ◽

2003 ◽

Vol 41 ◽

pp. S278-S279

Author(s):

Hoon-Kyo Kim ◽

Se-Hoon Lee ◽

Keunchil Park ◽

Cheolwon Suh ◽

Jun-Suk Kim ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Clinical Trial ◽

Small Cell Lung

Download Full-text

Phase II clinical trial of didemnin B in previously treated small cell lung cancer

Investigational New Drugs ◽

10.1007/bf00873966 ◽

1994 ◽

Vol 12 (3) ◽

pp. 243-249 ◽

Author(s):

Dong M. Shin ◽

Paul Y. Holoye ◽

Arthur Forman ◽

Rodger Winn ◽

Roman Perez-Soler ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Clinical Trial ◽

Small Cell Lung ◽

Previously Treated

Download Full-text

Abstract CT152: Phase II clinical trial results for 4-demethyl-4-cholesteryloxycarbonyl-penclomedine (DM-CHOC-PEN) in advanced non-small cell lung cancer (NSCLC) involving the CNS

10.1158/1538-7445.am2021-ct152 ◽

2021 ◽

Author(s):

Roy S. Weiner ◽

Lee Roy Morgan ◽

Marcus Ware ◽

Tallat Mahmood ◽

Craig Gordon ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Clinical Trial ◽

Small Cell Lung ◽

Clinical Trial Results

Download Full-text

Abstract 4664: Result of TORI L-03, a randomized, multicenter phase II clinical trial of erlotinib (E) or E + fulvestrant (F) in previously treated advanced non-small cell lung cancer (NSCLC).

10.1158/1538-7445.am2013-4664 ◽

2013 ◽

Author(s):

Edward B. Garon ◽

Jill M. Siegfried ◽

Steven M. Dubinett ◽

Robert M. Elashoff ◽

David J. Park ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Clinical Trial ◽

Small Cell Lung ◽

Multicenter Phase ◽

Previously Treated

Download Full-text

Tolerability of a combination of carboplatin and etoposide phosphate in elderly patients with small cell lung cancer. A multicentric phase II clinical trial

Lung Cancer ◽

10.1016/s0169-5002(00)80131-2 ◽

2000 ◽

Vol 29 (1) ◽

pp. 41 ◽

Author(s):

E Quoix ◽

J.L Breton ◽

C Daniel ◽

P Jacoulet ◽

D Debieuvre ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Clinical Trial ◽

Small Cell Lung ◽

Etoposide Phosphate

Download Full-text

Phase II Clinical Trial of Lobaplatin (D-19466) in Pretreated Patients with Small-Cell Lung Cancer

Oncology Research and Treatment ◽

10.1159/000218823 ◽

1996 ◽

Vol 19 (4) ◽

pp. 328-332 ◽

Author(s):

H.H. Fiebig ◽

H. Henß ◽

I. von Pawel ◽

U. Gatzemeier ◽

Ch. Manegold ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Clinical Trial ◽

Small Cell Lung ◽

Pretreated Patients

Download Full-text

C-kit protein expression in tumor specimens as a predictor of sensitivity to imatinib mesylate in patients with small cell lung cancer (SCLC): A phase II clinical trial

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7218 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7218-7218 ◽

Author(s):

L. M. Krug ◽

J. P. Crapanzano ◽

V. A. Miller ◽

C. G. Azzoli ◽

N. Rizvi ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Protein Expression ◽

Small Cell Lung Cancer ◽

Imatinib Mesylate ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Clinical Trial ◽

Small Cell Lung

Download Full-text

A phase II clinical trial of gemcitabine and imatinib mesylate for patients with recurrent non-small cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.19101 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 19101-19101

Author(s):

M. Eleff ◽

M. A. Sovak ◽

D. Greenberg ◽

L. Guensch ◽

P. Joyce ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Imatinib Mesylate ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Clinical Trial ◽

Small Cell Lung

Download Full-text

Outcomes from a Phase II Clinical Trial Evaluating the Systemic (Abscopal) Response from the Addition of Local Radiation to Standard-of-Care Immunotherapy for Metastatic Non-Small Cell Lung Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2019.06.1360 ◽

2019 ◽

Vol 105 (1) ◽

pp. E519

Author(s):

M.D. Mattes ◽

T.D. Eubank ◽

M. Almubarak ◽

A.P. Provenzano ◽

S. Wen ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Standard Of Care ◽

Phase Ii Clinical Trial ◽

Small Cell Lung ◽

Local Radiation

Download Full-text

Phase II clinical trial on docetaxel in the treatment of non-small-cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7352 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7352-7352

Author(s):

Y. Chen ◽

Y. Zhao ◽

Z. Chen ◽

M. Liao

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Clinical Trial ◽

Small Cell Lung

Download Full-text

cis-platinum (DDP) and VP 16-213 (etoposide) combination chemotherapy for advanced non-small cell lung cancer. A phase II clinical trial

European Journal of Cancer and Clinical Oncology ◽

10.1016/0277-5379(84)90080-4 ◽

1984 ◽

Vol 20 (3) ◽

pp. 347-351 ◽

Author(s):

P.S. Mitrou ◽

M. Graubner ◽

W.E. Berdel ◽

S. Mende ◽

C. Gropp ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Combination Chemotherapy ◽

Phase Ii Clinical Trial ◽

Small Cell Lung

Download Full-text